vs
Side-by-side financial comparison of Dream Finders Homes, Inc. (DFH) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.2× Dream Finders Homes, Inc.). Dream Finders Homes, Inc. runs the higher net margin — 4.8% vs 4.4%, a 0.4% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs -22.3%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $136.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 21.0%).
Dream Finders Homes, Inc. is a U.S. homebuilding firm that constructs and sells entry-level to luxury residential properties, including single-family homes and townhomes, across high-growth domestic markets. It also provides mortgage, title insurance and home warranty services for homebuyers.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
DFH vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $1.5B |
| Net Profit | $58.8M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 6.4% | 12.4% |
| Net Margin | 4.8% | 4.4% |
| Revenue YoY | -22.3% | 32.8% |
| Net Profit YoY | -54.9% | 143.8% |
| EPS (diluted) | $0.57 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | $969.8M | $1.4B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $989.9M | $1.1B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.0B | $1.0B | ||
| Q2 24 | $1.1B | $929.2M | ||
| Q1 24 | $827.8M | $751.7M |
| Q4 25 | $58.8M | $66.5M | ||
| Q3 25 | $47.0M | $124.8M | ||
| Q2 25 | $56.6M | $94.3M | ||
| Q1 25 | $54.9M | $1.3M | ||
| Q4 24 | $130.5M | $-151.9M | ||
| Q3 24 | $70.7M | $-121.3M | ||
| Q2 24 | $80.9M | $-120.4M | ||
| Q1 24 | $54.5M | $-251.2M |
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | 19.2% | 85.1% | ||
| Q1 24 | 18.0% | 83.4% |
| Q4 25 | 6.4% | 12.4% | ||
| Q3 25 | 6.3% | 11.5% | ||
| Q2 25 | 6.4% | 6.7% | ||
| Q1 25 | 7.2% | 1.0% | ||
| Q4 24 | 10.8% | -7.0% | ||
| Q3 24 | 9.2% | -12.0% | ||
| Q2 24 | 10.0% | -11.5% | ||
| Q1 24 | 8.6% | -34.8% |
| Q4 25 | 4.8% | 4.4% | ||
| Q3 25 | 4.8% | 8.8% | ||
| Q2 25 | 4.9% | 7.2% | ||
| Q1 25 | 5.5% | 0.1% | ||
| Q4 24 | 8.4% | -13.5% | ||
| Q3 24 | 7.0% | -12.1% | ||
| Q2 24 | 7.7% | -13.0% | ||
| Q1 24 | 6.6% | -33.4% |
| Q4 25 | $0.57 | $0.05 | ||
| Q3 25 | $0.47 | $0.08 | ||
| Q2 25 | $0.56 | $0.06 | ||
| Q1 25 | $0.54 | $0.00 | ||
| Q4 24 | $1.28 | $-0.10 | ||
| Q3 24 | $0.70 | $-0.09 | ||
| Q2 24 | $0.81 | $-0.09 | ||
| Q1 24 | $0.55 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $234.8M | $4.5B |
| Total DebtLower is stronger | $1.6B | $836.4M |
| Stockholders' EquityBook value | $1.4B | $4.4B |
| Total Assets | $3.7B | $8.2B |
| Debt / EquityLower = less leverage | 1.13× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $234.8M | $4.5B | ||
| Q3 25 | $251.0M | $4.0B | ||
| Q2 25 | $210.3M | $2.8B | ||
| Q1 25 | $297.5M | $2.5B | ||
| Q4 24 | $274.4M | $2.6B | ||
| Q3 24 | $204.9M | $2.7B | ||
| Q2 24 | $274.8M | $2.6B | ||
| Q1 24 | $239.4M | $2.8B |
| Q4 25 | $1.6B | $836.4M | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.4B | $4.4B | ||
| Q3 25 | $1.4B | $4.1B | ||
| Q2 25 | $1.3B | $3.8B | ||
| Q1 25 | $1.3B | $3.5B | ||
| Q4 24 | $1.2B | $3.3B | ||
| Q3 24 | $1.1B | $3.4B | ||
| Q2 24 | $1.0B | $3.4B | ||
| Q1 24 | $968.7M | $3.4B |
| Q4 25 | $3.7B | $8.2B | ||
| Q3 25 | $3.8B | $7.6B | ||
| Q2 25 | $3.7B | $6.3B | ||
| Q1 25 | $3.5B | $5.8B | ||
| Q4 24 | $3.3B | $5.9B | ||
| Q3 24 | $3.3B | $5.8B | ||
| Q2 24 | $3.0B | $5.7B | ||
| Q1 24 | $2.7B | $5.7B |
| Q4 25 | 1.13× | 0.19× | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.03× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $143.6M | $417.3M |
| Free Cash FlowOCF − Capex | $136.0M | $379.8M |
| FCF MarginFCF / Revenue | 11.2% | 25.4% |
| Capex IntensityCapex / Revenue | 0.6% | 2.5% |
| Cash ConversionOCF / Net Profit | 2.44× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $-126.4M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $143.6M | $417.3M | ||
| Q3 25 | $-131.0M | $402.6M | ||
| Q2 25 | $-68.5M | $263.6M | ||
| Q1 25 | $-44.7M | $44.1M | ||
| Q4 24 | $306.5M | $75.2M | ||
| Q3 24 | $-205.0M | $188.4M | ||
| Q2 24 | $-110.6M | $-95.6M | ||
| Q1 24 | $-247.5M | $-308.6M |
| Q4 25 | $136.0M | $379.8M | ||
| Q3 25 | $-135.7M | $354.5M | ||
| Q2 25 | $-78.8M | $219.8M | ||
| Q1 25 | $-47.9M | $-12.3M | ||
| Q4 24 | $302.6M | $-17.3M | ||
| Q3 24 | $-222.5M | $54.7M | ||
| Q2 24 | $-112.4M | $-205.5M | ||
| Q1 24 | $-249.6M | $-465.1M |
| Q4 25 | 11.2% | 25.4% | ||
| Q3 25 | -14.0% | 25.1% | ||
| Q2 25 | -6.8% | 16.7% | ||
| Q1 25 | -4.8% | -1.1% | ||
| Q4 24 | 19.4% | -1.5% | ||
| Q3 24 | -22.1% | 5.5% | ||
| Q2 24 | -10.6% | -22.1% | ||
| Q1 24 | -30.2% | -61.9% |
| Q4 25 | 0.6% | 2.5% | ||
| Q3 25 | 0.5% | 3.4% | ||
| Q2 25 | 0.9% | 3.3% | ||
| Q1 25 | 0.3% | 5.0% | ||
| Q4 24 | 0.3% | 8.2% | ||
| Q3 24 | 1.7% | 13.3% | ||
| Q2 24 | 0.2% | 11.8% | ||
| Q1 24 | 0.3% | 20.8% |
| Q4 25 | 2.44× | 6.28× | ||
| Q3 25 | -2.79× | 3.22× | ||
| Q2 25 | -1.21× | 2.79× | ||
| Q1 25 | -0.81× | 34.71× | ||
| Q4 24 | 2.35× | — | ||
| Q3 24 | -2.90× | — | ||
| Q2 24 | -1.37× | — | ||
| Q1 24 | -4.54× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DFH
| Midwest Segment | $454.2M | 37% |
| Southeast Segment | $397.5M | 33% |
| Mid Atlantic Segment | $307.3M | 25% |
| Financial Services Segment | $53.7M | 4% |
ONC
Segment breakdown not available.
